Skip to content

Evaluation of sleep-improvement effects of the capsules containing Valeriana fauriei root (VF) extract

A randomized, double-blind, placebo-controlled, crossover comparative study of evaluation of sleep-improvement effects of the capsules containing Valeriana fauriei root (VF) extract - Evaluation of sleep-improvement effects of the capsules containing VF extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048811
Enrollment
70
Registered
2022-09-04
Start date
2022-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 2 weeks Trial food: Soft capsule containing VF extract (1 g/1 capsule) Dosage and administration: Take 2 capsules (equivalent to 2 g of VF extract) with water 30 minutes before bedtime.

Sponsors

Nagoya City University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects with sleep problems. 2. Subjects with an AIS score of 6 or higher. 3. Subjects with written consent to take part in the trial. 4. Men or women aged 20 to 65. 5. Subjects with an easy intake of capsules. 6. Subjects who can complete the questionnaire via smartphone, tablet, or computer.

Exclusion criteria

Exclusion criteria: 1. Subjects currently being treated for severe renal or liver disease, heart, respiratory or endocrine disease, or other metabolic diseases. 2. Subjects currently taking medications that interfere with sleep (sleeping pills, antianxiety drugs) 3. Subjects allergic to gelatin. 4. Subjects work irregular/night/early morning shifts every day. 5. Women having the possibility or intention to become pregnant, lactating

Design outcomes

Primary

MeasureTime frame
Evaluation of sleep quality based on the Obstructive sleep apnea syndrome (OSA) Sleep Questionnaire.

Secondary

MeasureTime frame
Evaluation of sleep quality using the OSA Sleep Questionnaire for each sleep complaint on the Athens Insomnia Scale (AIS).

Countries

Japan

Contacts

Public ContactMisato Ota

Kuki Sangyo Co., Ltd. R&D Medicinal Department

m_oota@kuki-info.co.jp059-350-2050

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026